Regulatory
FDA Seeks First-of-Its-Kind Penalty for Firm Substituting Ingredients without Changing Labels
November 28th 2011The agency also notes it’s the first time it has taken legal action against a dietary supplement manufacturer of this size for failing to comply with dietary supplement current Good Manufacturing Practices.
Editorial: Will the Market Competition Urge GMP Compliance?
November 11th 2011It’s always a pleasure when FDA provides its GMP regulatory compliance updates. I’ve heard Brad Williams, manager of FDA’s Division of Dietary Supplement Programs, speak several times at industry events and, most recently, at October’s SupplySide West show in Las Vegas. Hearing firsthand from FDA how our industry is doing in terms of GMP compliance provides a good idea of where we are-and how far we have to go.
EU Health Claims Process Will Increase Consumer Confusion, Decrease Choice, EHPM Says
November 8th 2011“With a prediction of a 25% drop in the market for substances other than vitamins and minerals, the regulation will fail in its main objectives and severely damage the economic profitability of the sector.”
CRN Sends FDA More Comments on Revised Phytosterol Rule
October 31st 2011Moreover, the association argues, FDA’s proposed enforcement deadline of February 21, 2012, is “untenable” for supplement marketers, many of whom CRN contends would find it difficult to replace or reformulate current products in time.